These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 1709208)
1. [Tyrosine-phosphorylated proteins in human breast carcinoma]. Bretti S; Cappa AP; Comoglio PM; Di Renzo MF J Nucl Med Allied Sci; 1990; 34(4 Suppl):205-10. PubMed ID: 1709208 [TBL] [Abstract][Full Text] [Related]
2. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Ethier SP; Kokeny KE; Ridings JW; Dilts CA Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031 [TBL] [Abstract][Full Text] [Related]
3. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3. Alper O; Yamaguchi K; Hitomi J; Honda S; Matsushima T; Abe K Cell Growth Differ; 1990 Dec; 1(12):591-9. PubMed ID: 1981143 [TBL] [Abstract][Full Text] [Related]
4. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2. Wildenhain Y; Pawson T; Blackstein ME; Andrulis IL Oncogene; 1990 Jun; 5(6):879-83. PubMed ID: 1694290 [TBL] [Abstract][Full Text] [Related]
5. Proteins phosphorylated on tyrosine as markers of human tumor cell lines. Giordano S; Di Renzo MF; Cirillo D; Naldini L; Chiado'Piat L; Comoglio PM Int J Cancer; 1987 Apr; 39(4):482-7. PubMed ID: 2435663 [TBL] [Abstract][Full Text] [Related]
6. Direct identification of phosphotyrosine-containing proteins in some retrovirus-transformed cells by use of anti-phosphotyrosine antibody. Seki J; Owada MK; Sakato N; Fujio H Cancer Res; 1986 Feb; 46(2):907-16. PubMed ID: 2416436 [TBL] [Abstract][Full Text] [Related]
7. Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs. Lim YP; Wong CY; Ooi LL; Druker BJ; Epstein RJ Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3980-7. PubMed ID: 15217928 [TBL] [Abstract][Full Text] [Related]
8. Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity. Prat M; Di Renzo MF; Gaudino G; Ponzetto C; Comoglio PM Ann Ist Super Sanita; 1991; 27(1):175-81. PubMed ID: 1720292 [TBL] [Abstract][Full Text] [Related]
9. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. DiGiovanna MP; Stern DF Cancer Res; 1995 May; 55(9):1946-55. PubMed ID: 7728765 [TBL] [Abstract][Full Text] [Related]
10. Application of two-dimensional gel analysis to identification and characterization of tyrosine phosphorylated substrates for growth factor receptors. Hansen K; Møller JV Electrophoresis; 1993; 14(1-2):112-26. PubMed ID: 7681772 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the activity and phosphorylation of the lck protein in lymphoid cells. Hurley TR; Sefton BM Oncogene; 1989 Mar; 4(3):265-72. PubMed ID: 2468122 [TBL] [Abstract][Full Text] [Related]
12. Novel tyrosine phosphorylations accompany the activation of pp60c-src during chemical carcinogenesis. Kanner SB; Gilmer TM; Reynolds AB; Parsons JT Oncogene; 1989 Mar; 4(3):295-300. PubMed ID: 2468123 [TBL] [Abstract][Full Text] [Related]
13. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350 [TBL] [Abstract][Full Text] [Related]
14. Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry. Far DF; Peyron JF; Imbert V; Rossi B Cytometry; 1994 Apr; 15(4):327-34. PubMed ID: 7517816 [TBL] [Abstract][Full Text] [Related]
15. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP; Sefton BM Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525 [TBL] [Abstract][Full Text] [Related]
16. Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line. Giordano S; Di Renzo MF; Narsimhan RP; Tamagnone L; Gerbaudo EV; Chiadó-Piat L; Comoglio PM J Cell Biochem; 1988 Dec; 38(4):229-36. PubMed ID: 3241013 [TBL] [Abstract][Full Text] [Related]
17. Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Zhang HT; Zhang X; Zhao HZ; Kajino Y; Weber BL; Davis JG; Wang Q; O'Rourke DM; Zhang HB; Kajino K; Greene MI Oncogene; 1997 Jun; 14(24):2863-9. PubMed ID: 9205094 [TBL] [Abstract][Full Text] [Related]
18. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223 [TBL] [Abstract][Full Text] [Related]
19. Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate. Draetta G; Piwnica-Worms H; Morrison D; Druker B; Roberts T; Beach D Nature; 1988 Dec 22-29; 336(6201):738-44. PubMed ID: 2462672 [TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosyl-proteins in human breast cancer. Partanen S Anticancer Res; 1993; 13(5C):1777-80. PubMed ID: 7505541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]